Kestrel Medical Limited 04122830 false 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is wholesale of pharmaceutical goods and of other medical devices Digita Accounts Production Advanced 6.30.9574.0 true true 04122830 2024-01-01 2024-12-31 04122830 2024-12-31 04122830 core:CurrentFinancialInstruments 2024-12-31 04122830 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 04122830 core:Non-currentFinancialInstruments 2024-12-31 04122830 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 04122830 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-12-31 04122830 core:Goodwill 2024-12-31 04122830 core:OtherResidualIntangibleAssets 2024-12-31 04122830 core:PatentsTrademarksLicencesConcessionsSimilar 2024-12-31 04122830 core:FurnitureFittingsToolsEquipment 2024-12-31 04122830 core:LandBuildings 2024-12-31 04122830 core:OtherPropertyPlantEquipment 2024-12-31 04122830 bus:SmallEntities 2024-01-01 2024-12-31 04122830 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 04122830 bus:FullAccounts 2024-01-01 2024-12-31 04122830 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 04122830 bus:RegisteredOffice 2024-01-01 2024-12-31 04122830 bus:CompanySecretaryDirector2 2024-01-01 2024-12-31 04122830 bus:Director1 2024-01-01 2024-12-31 04122830 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 04122830 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-01-01 2024-12-31 04122830 core:Goodwill 2024-01-01 2024-12-31 04122830 core:OtherResidualIntangibleAssets 2024-01-01 2024-12-31 04122830 core:PatentsTrademarksLicencesConcessionsSimilar 2024-01-01 2024-12-31 04122830 core:FurnitureFittings 2024-01-01 2024-12-31 04122830 core:FurnitureFittingsToolsEquipment 2024-01-01 2024-12-31 04122830 core:LandBuildings 2024-01-01 2024-12-31 04122830 core:LeaseholdImprovements 2024-01-01 2024-12-31 04122830 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 04122830 core:PlantMachinery 2024-01-01 2024-12-31 04122830 countries:England 2024-01-01 2024-12-31 04122830 2023-12-31 04122830 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 04122830 core:Goodwill 2023-12-31 04122830 core:OtherResidualIntangibleAssets 2023-12-31 04122830 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 04122830 core:FurnitureFittingsToolsEquipment 2023-12-31 04122830 core:LandBuildings 2023-12-31 04122830 core:OtherPropertyPlantEquipment 2023-12-31 04122830 2023-01-01 2023-12-31 04122830 2023-12-31 04122830 core:CurrentFinancialInstruments 2023-12-31 04122830 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 04122830 core:Non-currentFinancialInstruments 2023-12-31 04122830 core:Non-currentFinancialInstruments core:AfterOneYear 2023-12-31 04122830 core:DevelopmentCostsCapitalisedDevelopmentExpenditure 2023-12-31 04122830 core:Goodwill 2023-12-31 04122830 core:OtherResidualIntangibleAssets 2023-12-31 04122830 core:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 04122830 core:FurnitureFittingsToolsEquipment 2023-12-31 04122830 core:LandBuildings 2023-12-31 04122830 core:OtherPropertyPlantEquipment 2023-12-31 iso4217:GBP xbrli:pure

Registration number: 04122830

Kestrel Medical Limited

Unaudited Filleted Financial Statements

for the Year Ended 31 December 2024

 

Kestrel Medical Limited

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 8

 

Kestrel Medical Limited

Company Information

Directors

Mr I Ponsford

Mrs M Ponsford

Company secretary

Mrs M Ponsford

Registered office

Kestrel House
7 Moor Road
Broadstone
Poole
Dorset
BH18 8AZ

Accountants

Wilkinsons Accountants Limited
Chartered Certified Accountants
The Old Exchange
521 Wimborne Road East
Ferndown
Dorset
BH22 9NH

 

Kestrel Medical Limited

(Registration number: 04122830)
Balance Sheet as at 31 December 2024

Note

2024
£

2023
£

Fixed assets

 

Intangible assets

4

26,732

24,531

Tangible assets

5

23,544

26,622

 

50,276

51,153

Current assets

 

Stocks

6

462,548

679,019

Debtors

7

400,524

400,520

Cash at bank and in hand

 

646,117

601,504

 

1,509,189

1,681,043

Creditors: Amounts falling due within one year

8

(426,954)

(642,602)

Net current assets

 

1,082,235

1,038,441

Total assets less current liabilities

 

1,132,511

1,089,594

Creditors: Amounts falling due after more than one year

8

(6,667)

(16,667)

Provisions for liabilities

9,385

-

Net assets

 

1,135,229

1,072,927

Capital and reserves

 

Called up share capital

100

100

Retained earnings

1,135,129

1,072,827

Shareholders' funds

 

1,135,229

1,072,927

For the financial year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 September 2025 and signed on its behalf by:
 

.........................................
Mr I Ponsford
Director

 

Kestrel Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Kestrel House
7 Moor Road
Broadstone
Poole
Dorset
BH18 8AZ
England

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling, which is the functional currency of the entity and rounded to the nearest £1.

Going concern

The financial statements have been prepared on a going concern basis.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

 

Kestrel Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

2

Accounting policies (continued)

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Leasehold property

10 years straight line

Fixtures and fittings

20% on reducing balance

Plant and machinery

25% on reducing balance

Goodwill

The Goodwill owned by the company is written off on a straight line basis over its estimated useful life of ten years.

Intangible assets

Intangible assets are stated at their historical cost and amortised on a straight-line basis over their expected useful lives.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Trademarks

7 years straight line

Stocks

Stock is valued at the lower of cost and net realisable value, after due regard for obsolete and slow moving stocks. Net realisable value is based on selling price less anticipated costs to completion and selling costs.

 

Kestrel Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

2

Accounting policies (continued)

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 7 (2023 - 7).

 

Kestrel Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

4

Intangible assets

Goodwill
 £

Patents
 £

Website development costs
 £

Other intangible assets
 £

Total
£

Cost or valuation

At 1 January 2024

277,771

6,675

17,850

24,531

326,827

Additions acquired separately

-

-

-

6,656

6,656

At 31 December 2024

277,771

6,675

17,850

31,187

333,483

Amortisation

At 1 January 2024

277,771

6,675

17,850

-

302,296

Amortisation charge

-

-

-

4,455

4,455

At 31 December 2024

277,771

6,675

17,850

4,455

306,751

Carrying amount

At 31 December 2024

-

-

-

26,732

26,732

At 31 December 2023

-

-

-

24,531

24,531

5

Tangible assets

Land and buildings
£

Fixtures and fittings
 £

Plant and machinery
 £

Total
£

Cost or valuation

At 1 January 2024

31,911

61,396

12,456

105,763

Additions

-

3,032

-

3,032

At 31 December 2024

31,911

64,428

12,456

108,795

Depreciation

At 1 January 2024

24,668

42,384

12,089

79,141

Charge for the year

1,810

4,208

92

6,110

At 31 December 2024

26,478

46,592

12,181

85,251

Carrying amount

At 31 December 2024

5,433

17,836

275

23,544

At 31 December 2023

7,243

19,012

367

26,622

Included within the net book value of land and buildings above is £5,432 (2023 - £7,243) in respect of long leasehold land and buildings.
 

 

Kestrel Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

6

Stocks

2024
£

2023
£

Other inventories

462,548

679,019

7

Debtors

2024
£

2023
£

Trade debtors

365,182

311,715

Prepayments

35,342

58,032

Other debtors

-

30,773

400,524

400,520

8

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Loans and borrowings

9

10,000

10,000

Trade creditors

 

217,552

217,883

Taxation and social security

 

92,129

162,536

Accruals and deferred income

 

99,902

210,095

Other creditors

 

7,371

42,088

 

426,954

642,602

Creditors: amounts falling due after more than one year

Note

2024
£

2023
£

Due after one year

 

Loans and borrowings

9

6,667

16,667

9

Loans and borrowings

2024
£

2023
£

Non-current loans and borrowings

Bank borrowings

6,667

16,667

 

Kestrel Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2024

9

Loans and borrowings (continued)

2024
£

2023
£

Current loans and borrowings

Bank borrowings

10,000

10,000

Bank security

The Company's bankers hold a fixed and floating charge over the company's assets.

10

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £28,681 (2023 - £35,802). This includes annual rental and leasing commitments of £25,121 (2023 - £25,121)